Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Argus Research Maintains Buy on Bio-Techne, Raises Price Target to $490

Argus Research analyst David Toung maintains Bio-Techne (NASDAQ:TECH) with a Buy and raises the price target from $440 to $490.
byBenzinga Newsdesk
June 18, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Argus Research analyst David Toung maintains Bio-Techne (NASDAQ:TECH) with a Buy and raises the price target from $440 to $490.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0